Detailed price information for Horizon Quantum Holdings Ltd Cl A (HQ-Q) from The Globe and Mail including charting and trades.

Google reported the first confirmed AI-assisted zero-day exploit, raising new concerns about logic flaws, supply chain risk, and containment.

Recursive Superintelligence Inc., a startup that hopes to develop self-improving artificial intelligence models, launched today with $650 million in funding. Alphabet Inc.’s GV fund and Greycroft led ...

First AI zero-day: Google detected the first confirmed AI-created zero-day exploit, aimed at bypassing 2FA in a popular ...

It’s not unusual for kindergarten teachers to spend a chunk of their school days trying to get their young learners to stop talking. Advice on managing classroom noise is easy to find. Far rarer, ...

The U.S. middle class is shrinking, but not because more Americans are poorer. Instead, more households are climbing into the echelons of the upper middle class due to income gains in recent decades, ...

Shares of Recursion Pharmaceuticals (RXRX) spiked on Wednesday after the AI-driven drug developer significantly exceeded Street forecasts with its Q4 2025 financials, thanks primarily to a milestone ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Dany Lepage discusses the architectural ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Microsoft has added official Python support to Aspire 13, expanding the platform beyond .NET and JavaScript for building and running distributed apps. Documented today in a Microsoft DevBlogs post, ...

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. LONDON — In the year-plus since ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...